Found: 6
Select item for more details and to access through your institution.
COVID-19-associated necrotizing encephalopathy presenting without active respiratory symptoms: a case report with histopathology.
- Published in:
- Journal of NeuroVirology, 2022, v. 28, n. 1, p. 172, doi. 10.1007/s13365-021-01042-3
- By:
- Publication type:
- Article
Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain.
- Published in:
- Molecular Neurodegeneration, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13024-021-00509-5
- By:
- Publication type:
- Article
Sensitivity and specificity of phospho‐Ser129 α‐synuclein monoclonal antibodies.
- Published in:
- Journal of Comparative Neurology, 2018, v. 526, n. 12, p. 1978, doi. 10.1002/cne.24468
- By:
- Publication type:
- Article
Breathing new life into an old target: pulmonary disease drugs for Parkinson's disease therapy.
- Published in:
- Genome Medicine, 2017, v. 9, p. 1, doi. 10.1186/s13073-017-0483-4
- By:
- Publication type:
- Article
G2019S-LRRK2 Expression Augments α-Synuclein Sequestration into Inclusions in Neurons.
- Published in:
- Journal of Neuroscience, 2016, v. 38, n. 28, p. 7415, doi. 10.1523/JNEUROSCI.3642-15.2016
- By:
- Publication type:
- Article
The G2019S LRRK2 mutation increases myeloid cell chemotactic responses and enhances LRRK2 binding to actin-regulatory proteins.
- Published in:
- Human Molecular Genetics, 2015, v. 24, n. 15, p. 4250, doi. 10.1093/hmg/ddv157
- By:
- Publication type:
- Article